MINNEAPOLIS, Minnesota – The Minnesota High Tech Association (MHTA) has named Imbio as a finalist in the Healthcare – Small & Growing category for the 2015 Tekne Awards, which will be held at the Minneapolis Convention Center on Thursday, Nov. 18. The Tekne Awards honor Minnesota companies and individuals who have shown superior technology innovation and leadership.
Imbio is a fast-growing innovator in quantitative medical imaging. Originally founded to commercialize breakthrough imaging biomarkers developed by leading universities and research institutions, Imbio is quickly building a quantitative imaging portfolio to enable more personalized diagnosis and patient care in smoking-related diseases. Lung Density Analysis™ is the company’s FDA cleared and CE-marked product to assist diagnosis of COPD, which affects more than 65 million people globally. In addition to proprietary image analysis, Imbio is unique in providing fully-automated solutions that integrate with hospitals’ PACS systems and improve physician productivity. Imbio is also changing the way hospitals purchase advanced imaging with flexible SaaS offerings that make the company’s unique analysis affordable and accessible to many more healthcare providers.
“Imbio is honored to be selected as a TEKNE finalist along with the other businesses that are advancing the science and technology sector in Minnesota”, said Cynthia Maier, CEO, Imbio. “We will continue our mission to improve diagnosis and care for patients suffering from COPD and other chronic diseases, and we are proud to help highlight Minnesota as a global leader in technology.”
Presented by the MHTA, the Tekne Awards recognize Minnesota’s best and brightest technology users and developers in innovation, development, education, commercialization and management. This year’s 16th annual awards ceremony will commence at 7 p.m. on Nov 18th and will be emceed by WCCO anchor Amelia Santaniello. A full list of finalists is available online at http://www.tekneawards.org.
Imbio is transforming medical image analysis by making breakthrough Radiology diagnostics accessible and affordable for all physicians. Imbio offers quantitative biomarker analyses that are fully automated to preserve physicians’ time while providing data and visualization to help make better personalized patient care decisions. Imbio’s flexible Cloud and Enterprise SaaS solutions eliminate the cost and complexity that have kept valuable advanced imaging out of reach for many healthcare providers in the past. Imbio’s FDA cleared and CE marked Lung Density Analysis™ is part of the company’s portfolio of imaging solutions for smoking-related diseases. For more information visit www.imbio.com.
About Minnesota High Tech Association (MHTA)
MHTA is an innovation and technology association united in fueling Minnesota’s prosperity. We help bring together the people of Minnesota’s technology ecosystem and lead the charge in directing technology issues to Minnesota’s state capitol. MHTA is the only membership organization that represents Minnesota’s entire technology-based economy. MHTA members include organizations of every size − involved in virtually every aspect of technology creation, production, application and education in Minnesota. Find out more online at http://www.mhta.org or follow MHTA on Twitter at http://twitter.com/MHTA.
Can Akgun, Ph.D.
Business Development Manager